Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Myelodysplastic-Myeloproliferative Diseases × Vemurafenib × 1 year × Clear all

Sponsor

Conditions

Melanoma 8 Neoplasms 7 Thyroid Neoplasms 4 Thyroid Cancer, Papillary 4 Neoplasm Metastasis 4 Leukemia, Hairy Cell 4 Multiple Myeloma 3 Lymphoma, Non-Hodgkin 3 Carcinoma, Non-Small-Cell Lung 3 Thyroid Carcinoma, Anaplastic 2 Skin Neoplasms 2 Neoplasms by Site 2 Neoplasms by Histologic Type 2 Hematologic Neoplasms 2 Glioma 2 Colorectal Neoplasms 2 Xanthogranuloma, Juvenile 1 Wilms Tumor 1 Thyroid cancer, follicular 1 Skin Diseases 1 Sarcoma, Ewing 1 Sarcoma 1 Rhabdomyosarcoma 1 Rhabdoid Tumor 1 Recurrence 1 Ovarian Neoplasms 1 Osteosarcoma 1 Noonan syndrome 3 1 Neuroectodermal Tumors, Primitive, Peripheral 1 Neuroblastoma 1

Interventions

Specimen Handling 7 Biopsy 6 Cyclophosphamide 5 ruxolitinib 4 Mycophenolic Acid 4 Busulfan 4 fludarabine phosphate 3 fludarabine 3 Whole-Body Irradiation 3 Tacrolimus 3 Melphalan 3 Injections 3 Decitabine 3 Cyclosporine 3 Azacitidine 3 venetoclax 2 decitabine and cedazuridine drug combination 2 Sirolimus 2 Methotrexate 2 Granulocyte Colony-Stimulating Factor 2 veliparib 1 tocilizumab 1 tagraxofusp 1 posaconazole 1 peginterferon alfa-2b 1 onvansertib 1 merphos 1 iadademstat 1 gilteritinib 1 fedratinib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡